Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
I’ve written about physicians’ financial conflicts of interest at The Upshot. I’ve made a Healthcare Triage episode, too, if you prefer that medium. As this
I am a frequent guest on Stand Up! with Pete Dominick, which airs on Sirius/XM radio, channel 104 from 6-9AM Eastern. It immediately replays on the channel, so
There’s a piece in the NEJM that’s so, so, so worth your time. “High-Cost Generic Drugs — Implications for Patients and Policymakers“: It is well
I don’t have much to say about the latest kerfuffle over what Jonathan Gruber said—you can find coverage pretty much everywhere—but I’m skeptical of the claim
If you’re interested in the Affordable Care Act’s 2.3% medical device excise tax (pro, con, or neutral), you should read the Congressional Research Service’s economic
A couple of months ago, a very nice guy names Peter Musser asked me if he could come to my office to talk to me
Every year, I like to write about the Health Care Cost Institute’s annual report on costs and utilization. The 2013 report was just released. There’s a
Last week’s decision by the Supreme Court to hear King v. Burwell understandably alarmed Affordable Care Act proponents. A ruling for King would remove the law’s premium subsidies
I absolutely can’t comment on the legal aspects of this, nor would I want to. Nick is all over it, and I defer to him.
The following originally appeared on The Upshot (copyright 2014, The New York Times Company). One longstanding concern about Medicaid is that too few doctors will accept it,
In one of our first episodes of Healthcare Triage, we discussed how placebo controlled randomized controlled trials showed that sugar doesn’t make kids hyper. Placebos,
The following originally appeared on the JAMA Forum. The headline of a mid-September op-ed in The Wall Street Journal by Kenneth Davis, MD, CEO and